Skip to main content

Sylvia Cheung

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Sylvia Cheung

Earlier roles on record: CFO at Anika Therapeutics, Inc. (ANIK) until August 21, 2020. The proxy statement of Anika Therapeutics, Inc. reports total compensation of $1,308,534 for Sylvia Cheung in fiscal 2020, including a base salary of $294,252. Disclosed compensation is on record for 4 fiscal years. Sylvia Cheung has spoken on 2 earnings calls across 1 company, most recently for Anika Therapeutics, Inc. on July 30, 2020.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Anika Therapeutics, Inc. (ANIK) $294,252 $1,308,534
2019 Anika Therapeutics, Inc. (ANIK) $392,094 $1,218,867
2018 Anika Therapeutics, Inc. (ANIK) $371,653 $1,287,202
2017 Anika Therapeutics, Inc. (ANIK) $359,085 $1,272,686

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.